NOVO NORDISK INC. for NOVO NORDISK INC.

Taxation/Internal Revenue Code TAX

Protecting Americans from Tax Hikes Act of 2015(PATH) provision of P.L. 114-113 FY16 Consolidated Appropriations; H.R. 880 R&D tax credit; corporate tax inversion generally and in amendments to S.Con.Res.11 FY16 Senate Budget Resolution and S. 1376 FY16 National Defense Authorization Act; interest deductibility IRC 163(j); Treasury proposed debt and equity regulations (Sec. 385)

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Natl Institutes of Health (NIH); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Indian Health Service; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); SENATE

Bills named: H.R. 880 (114th), S. 1376 (114th), S.Con.Res. 11 (114th)

Health Issues HCR

National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day and Growth Awareness Week.

Contacted: Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); SENATE; Natl Institutes of Health (NIH); Treasury, Dept of; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Indian Health Service; Labor, Dept of (DOL); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3742 (114th), H.R. 3658 (114th), H.R. 1192 (114th), S. 2023 (114th), H.R. 744 (114th), S. 320 (114th), H.R. 1190 (114th), S. 141 (114th), H.R. 2651 (114th), H.R. 3513 (114th), S. 586 (114th), S. 84 (114th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Special Diabetes Program, CHIP, and childhood obesity in P.L. 114-10 Medicare Access and CHIP Reauthorization Act of 2015 (MACRA); H.R. 2102 and S.1131 Medicare Diabetes Prevention Act; H.R. 2404 and S. 1509 Treat and Reduce Obesity Act; Issues related to medical nutrition therapy services to such beneficiaries with pre-diabetes or with risk factors for developing type 2 diabetes H.R. 1686 Medical Nutrition Therapy 2015; issues related to patient diabetes education in H.R. 1726 Access to Quality Diabetes Education Act of 2015; Continuous Glucose Monitoring (CGM); Medicare reimbursement of A1C for diabetes screening, and diabetes screening generally; H.R. 1021 Protecting the Integrity of Medicare Act (PIMA) of 2015; H.R.2005 and S. 1083 Medicare Drug Savings Act of 2015; Physician Quality and Reporting System (PQRS); CMMI Part B Demonstration

Contacted: Treasury, Dept of; Food & Drug Administration (FDA); Indian Health Service; Centers For Disease Control & Prevention (CDC); SENATE; Executive Office of the President (EOP); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL)

Bills named: H.R. 1686 (114th), S. 1509 (114th), H.R. 2005 (114th), S. 1083 (114th), H.R. 2404 (114th), S. 1131 (114th), H.R. 1726 (114th), H.R. 2102 (114th), H.R. 1021 (114th)

Budget/Appropriations BUD

Issues related to National Diabetes Prevention Program in FY17 Labor/HHS/Education Appropriations, P.L. 114-113 FY16 Consolidated Appropriations, and P.L. 113-235 FY15 Consolidated and Continuing Appropriations; Issues related to Medicare Part D, FDA, patents, and federal procurement in S.Con.Res.11 FY16 Senate Budget Resolution and H.Con.Res.27 House Budget Resolution; H.R. 3660 and S.3126 Preventive Health Savings Act

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Indian Health Service; Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Executive Office of the President (EOP)

Bills named: S.Con.Res. 11 (114th), S. 3126 (114th), H.Con.Res. 27 (114th), H.R. 3660 (114th)

Pharmacy PHA

P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B; H.R.6 21st Century Cures Act; FDA in HR 3049 FY16 Agriculture Appropriations

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Indian Health Service; Food & Drug Administration (FDA); Treasury, Dept of; Labor, Dept of (DOL); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA)

Bills named: H.R. 3049 (114th), H.R. 6 (114th)

Copyright/Patent/Trademark CPT

H.R. 9 Innovation Act and and S. 1137 PATENT Act (patent litigation and assertion); S.1890 and H.R.3326 Defend Trade Secrets Act of 2015

Contacted: Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Treasury, Dept of; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Indian Health Service; Executive Office of the President (EOP); Natl Institutes of Health (NIH)

Bills named: S. 1137 (114th), H.R. 9 (114th), S. 1890 (114th), H.R. 3326 (114th)

Trade (domestic/foreign) TRD

P.L. 114-26 Bipartisan Congressional Trade Priorities and Accountability Act of 2015; EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property, regulatory harmonization)

Contacted: Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Indian Health Service

Defense DEF

Issues related to TRICARE pharmacy benefit in HR4909 and S 2943 FY17 National Defense Authorization Act.

Contacted: Centers For Medicare and Medicaid Services (CMS); Indian Health Service; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Treasury, Dept of; Health Resources & Services Administration (HRSA); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: H.R. 4909 (114th)